Christopher Strouse

Has grant

Iowa State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Comparative Effectiveness Research Strategies Assessing Bendamustine Dosing in Follicular Lymphoma

Open Date: 2020-04-01

Close Date: 2022-10-31

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Matthew Maurer

Assistant Professor of Biostatistics and Medicine

Mayo Clinic Rochester

UNITED STATES

View details

Umar Farooq

Assistant Professor

University of Iowa Healthcare

UNITED STATES

View details

Neil Bailey

UNITED STATES

View details

Hemant Murthy

assistant professor of medicine

Mayo Clinic Research Florida

UNITED STATES

View details

Bradley McDowell

The University of Iowa

UNITED STATES

View details

Ran Reshef

UNITED STATES

View details

UNITED STATES

View details

David Bond

Associate Professor

Ohio State University

UNITED STATES

View details

Annette J. Schlueter

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Strouse

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (19)

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma

Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with <i>TP53</i> mutation; a referral center experience

Clinical outcomes of patients receiving three versus four doses of methotrexate with concomitant antithymocyte globulin in match unrelated donor allogeneic stem cell transplant: A single‐center experience

Clinical Outcomes of TP53 Mutated Myelodysplastic Syndrome/Acute Myeloid Leukemia; A Single Center Experience

Identification of Pre-Treatment Clinical Risk Factors Predictive of Inferior Survival and Increased Risk of Treatment Failure in CD19 Chimeric Antigen Receptor T Cell Recipients with Large B Cell Lymphoma.

Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy and Teclistamab in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease: A Real-World Experience of the US Myeloma Innovations Research Collaborative (USMIRC)

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience from the US Myeloma Innovations Research Collaborative (USMIRC)

VD-PACE As Salvage and Bridging Therapy to Transplant and Cellular Therapy in Triple Class Relapsed/Refractory Multiple Myeloma

Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients

A tale of two peripheral blood CD34+ cell counts: Evaluation of unexpectedly high values prior to peripheral stem cell collection

Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.

Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.

T cells, particularly activated CD4<sup>+</sup> cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity.

Collaborators (14)

Matthew Maurer

Umar Farooq

Neil Bailey

Hemant Murthy

Bradley McDowell

Ran Reshef

george weiner

Samer Al Hadidi

Meredith G. Parsons

Michael Spinner

Muhammad Hamid

Hillard M. Lazarus

David Bond

Annette J. Schlueter

Make your next move.